{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:13:56Z","timestamp":1791400436023,"version":"4.3.3"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT100291MA"],"award-info":[{"award-number":["WT100291MA"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR K019090"],"award-info":[{"award-number":["MR K019090"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 CA100730-11A1"],"award-info":[{"award-number":["P01 CA100730-11A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA63417-15"],"award-info":[{"award-number":["R01 CA63417-15"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50 CA094056-12"],"award-info":[{"award-number":["P50 CA094056-12"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["LLS 6067-10"],"award-info":[{"award-number":["LLS 6067-10"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.coviro.2015.09.004","type":"journal-article","created":{"date-parts":[[2015,9,27]],"date-time":"2015-09-27T07:46:54Z","timestamp":1443340014000},"page":"93-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"special_numbering":"C","title":["How does HTLV-1 cause adult T-cell leukaemia\/lymphoma (ATL)?"],"prefix":"10.1016","volume":"14","author":[{"given":"Charles RM","family":"Bangham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Ratner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2015.09.004_bib0435","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrc2111","article-title":"Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation","volume":"7","author":"Matsuoka","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.coviro.2015.09.004_bib0440","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3390\/v3060794","article-title":"Molecular aspects of HTLV-1 entry: functional domains of the HTLV-1 surface subunit (SU) and their relationships to the entry receptors","volume":"3","author":"Jones","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.coviro.2015.09.004_bib0445","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3390\/v3071131","article-title":"Molecular determinants of human T-lymphotropic virus type 1 transmission and spread","volume":"3","author":"Lairmore","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.coviro.2015.09.004_bib0450","doi-asserted-by":"crossref","first-page":"e1004454","DOI":"10.1371\/journal.ppat.1004454","article-title":"Co-dependent of HTLV-1 p12 and p8 function in virus persistence","volume":"10","author":"Pise-Masison","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2015.09.004_bib0455","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1182\/blood-2010-05-284141","article-title":"Requirement of the human T-cell leukemia virus p12 and p30 products for infectivity of human dendritic cells and macaques but not rabbits","volume":"116","author":"Valeri","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.coviro.2015.09.004_bib0460","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3389\/fmicb.2012.00400","article-title":"Overview on HTLV-1 p12, p8, p30, p13: accomplices in persistent infection and viral pathogenesis","volume":"3","author":"Bai","year":"2012","journal-title":"Front Microbiol"},{"key":"10.1016\/j.coviro.2015.09.004_bib0465","doi-asserted-by":"crossref","first-page":"20738","DOI":"10.1073\/pnas.1009635107","article-title":"Human T-cell leukemia virus type 1 p8 protein increases cellular conduits and virus transmission","volume":"107","author":"Prooyen","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2015.09.004_bib0470","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.virol.2014.12.008","article-title":"Acetylation of the c-MYC oncoprotein is required for cooperation with the HTLV-1 p30II accessory protein and the induction of oncogenic cellular transformation by p30II\/c-MYC","volume":"475","author":"Romeo","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2015.09.004_bib0475","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3389\/fmicb.2012.00247","article-title":"HBZ and its roles in HTLV-1 oncogenesis","volume":"3","author":"Zhao","year":"2012","journal-title":"Front Microbiol"},{"key":"10.1016\/j.coviro.2015.09.004_bib0480","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/B978-0-444-53488-0.00024-9","article-title":"Neurologic disease due to HTLV-1 infection","volume":"123","author":"McKendall","year":"2014","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.coviro.2015.09.004_bib0485","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/ICU.0b013e328358b9ec","article-title":"HTLV infection and the eye","volume":"23","author":"Kamoi","year":"2012","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.coviro.2015.09.004_bib0490","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1349-7006.2007.00456.x","article-title":"Pathological features of diseases associated with human T-cell leukemia virus type I","volume":"98","author":"Ohshima","year":"2007","journal-title":"Cancer Sci"},{"key":"10.1016\/j.coviro.2015.09.004_bib0495","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.virol.2012.09.028","article-title":"HTLV-1: persistence and pathogenesis","volume":"435","author":"Cook","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2015.09.004_bib0500","doi-asserted-by":"crossref","first-page":"e517","DOI":"10.1016\/S1470-2045(14)70202-5","article-title":"Human T-cell leukaemia virus type I and adult T-cell leukaemia\u2013lymphoma","volume":"15","author":"Ishitsuka","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.coviro.2015.09.004_bib0505","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1084\/jem.20101095","article-title":"Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemia","volume":"207","author":"ElHajj","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.coviro.2015.09.004_sbref0510","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1182\/blood-2014-03-560060","article-title":"Preclinical efficacy of the synthetic retinoid ST1926 for treating adult T-cell leukemia\/lymphoma","volume":"124","author":"ElHajj","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.coviro.2015.09.004_sbref0515","series-title":"Randomized Phase II Study of Mogamulizumab (KW-0761) Plus VCAP-AMP-VECP (mLSG15) versus mLSG15 Alone for Newly Diagnosed Aggressive Adult T-cell Leukemia\u2013Lymphoma (ATL)","author":"Tatsuro","year":"2013"},{"key":"10.1016\/j.coviro.2015.09.004_bib0520","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.3390\/v3081374","article-title":"HTLV-1 and innate immunity","volume":"3","author":"Journo","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.coviro.2015.09.004_bib0525","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0022-510X(91)90125-Q","article-title":"Cellular immune surveillance against HTLV-I infected T lymphocytes in HTLV-I associated myelopathy\/tropical spastic paraparesis (HAM\/TSP)","volume":"105","author":"Fujihara","year":"1991","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.coviro.2015.09.004_bib0530","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1182\/blood-2002-09-2855","article-title":"Low frequency of CD94\/NKG2A+T lymphocytes in patients with HTLV-1-associated myelopathy\/tropical spastic paraparesis, but not in asymptomatic carriers","volume":"102","author":"Saito","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.coviro.2015.09.004_bib0535","doi-asserted-by":"crossref","first-page":"e1002480","DOI":"10.1371\/journal.ppat.1002480","article-title":"Systems biology approaches reveal a specific IFN-inducible signature in HTLV-1 associated myelopathy","volume":"8","author":"Tattermusch","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2015.09.004_bib0540","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0165-5728(91)90056-D","article-title":"Natural killer (NK) cells in HTLV-I-associated myelopathy\/tropical spastic paraparesis-decrease in NK cell subset populations and activity in HTLV-I seropositive individuals","volume":"33","author":"Yu","year":"1991","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.coviro.2015.09.004_bib0545","doi-asserted-by":"crossref","first-page":"5101","DOI":"10.1128\/JVI.02564-08","article-title":"Stromal cell-mediated suppression of human T-cell leukemia virus type 1 expression in vitro and in vivo by type I interferon","volume":"83","author":"Kinpara","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2015.09.004_bib0550","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1182\/blood.V98.3.721","article-title":"High production of interferon gamma but not interleukin-2 by human T-lymphotropic virus type I-infected peripheral blood mononuclear cells","volume":"98","author":"Hanon","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.coviro.2015.09.004_bib0555","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1200\/JCO.2010.28.0669","article-title":"Meta-analysis on the use of zidovudine and interferon-alpha in adult T-cell leukemia\/lymphoma showing improved survival in the leukemic subtypes","volume":"28","author":"Bazarbachi","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.coviro.2015.09.004_bib0560","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1086\/340537","article-title":"Virus markers associated with vertical transmission of human T lymphotropic virus type 1 in Jamaica","volume":"34","author":"Hisada","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coviro.2015.09.004_bib0565","doi-asserted-by":"crossref","first-page":"6035","DOI":"10.1038\/sj.onc.1208970","article-title":"Cellular immune response to HTLV-1","volume":"24","author":"Bangham","year":"2005","journal-title":"Oncogene"},{"issue":"Suppl. 2","key":"10.1016\/j.coviro.2015.09.004_bib0570","doi-asserted-by":"crossref","first-page":"S187","DOI":"10.1086\/344269","article-title":"Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease","volume":"186","author":"Jacobson","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2015.09.004_bib0575","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/348245a0","article-title":"Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease","volume":"348","author":"Jacobson","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2015.09.004_bib0580","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1002\/eji.200939451","article-title":"CTL quality and the control of human retroviral infections","volume":"39","author":"Bangham","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.coviro.2015.09.004_bib0585","doi-asserted-by":"crossref","first-page":"7278","DOI":"10.4049\/jimmunol.165.12.7278","article-title":"The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection","volume":"165","author":"Jeffery","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2015.09.004_bib0590","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1073\/pnas.96.7.3848","article-title":"HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy","volume":"96","author":"Jeffery","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2015.09.004_bib0595","doi-asserted-by":"crossref","first-page":"e1002270","DOI":"10.1371\/journal.ppat.1002270","article-title":"KIR2DL2 enhances protective and detrimental HLA class I-mediated immunity in chronic viral infection","volume":"7","author":"Seich al Basatena","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2015.09.004_bib0600","doi-asserted-by":"crossref","first-page":"e1001117","DOI":"10.1371\/journal.ppat.1001117","article-title":"HLA class I binding of HBZ determines outcome in HTLV-1 infection","volume":"6","author":"MacNamara","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2015.09.004_bib0605","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1182\/blood.V99.9.3335","article-title":"High frequencies of Th1-type CD4(+) T cells specific to HTLV-1 Env and Tax proteins in patients with HTLV-1-associated myelopathy\/tropical spastic paraparesis","volume":"99","author":"Goon","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.coviro.2015.09.004_bib0610","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4049\/jimmunol.0903846","article-title":"Human T-lymphotropic virus type 1-induced CC chemokine ligand 22 maintains a high frequency of functional FoxP3+regulatory T cells","volume":"185","author":"Toulza","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2015.09.004_bib0615","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1182\/blood-2007-10-118539","article-title":"High frequency of CD4+FoxP3+cells in HTLV-1 infection: inverse correlation with HTLV-1-specific CTL response","volume":"111","author":"Toulza","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.coviro.2015.09.004_bib0620","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1172\/JCI23913","article-title":"Virus-induced dysfunction of CD4+CD25+ T cells in patients with HTLV-I-associated neuroimmunological disease","volume":"115","author":"Yamano","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coviro.2015.09.004_bib0625","doi-asserted-by":"crossref","first-page":"e1003630","DOI":"10.1371\/journal.ppat.1003630","article-title":"HTLV-1 bZIP factor induces inflammation through labile Foxp3 expression","volume":"9","author":"Yamamoto-Taguchi","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2015.09.004_bib0630","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/B978-0-12-385524-4.00004-0","article-title":"Cell leukemia\/lymphoma: FoxP3(+) cells and the cell-mediated immune response to HTLV-1","volume":"111","author":"Bangham","year":"2011","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.coviro.2015.09.004_bib0635","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1002\/ijc.24664","article-title":"FoxP3+ regulatory T cells are distinct from leukemia cells in HTLV-1-associated adult T-cell leukemia","volume":"125","author":"Toulza","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.coviro.2015.09.004_bib0640","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.coviro.2013.08.010","article-title":"Human T-cell leukemia virus type 1: replication, proliferation and propagation by Tax and HTLV-1 bZIP factor","volume":"3","author":"Matsuoka","year":"2013","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.coviro.2015.09.004_bib0645","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1073\/pnas.1419198112","article-title":"TCF1 and LEF1 act as T-cell intrinsic HTLV-1 antagonists by targeting Tax","volume":"112","author":"Ma","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2015.09.004_sbref0650","doi-asserted-by":"crossref","first-page":"31954","DOI":"10.1074\/jbc.M110.148718","article-title":"Acitvator-dependent p300 acetylation of chromatin in vitro: Enhancement of transcription by disruption of repressive nucleosome\u2013nucleosome interactions","volume":"285","author":"Szerlong","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coviro.2015.09.004_sbref0655","doi-asserted-by":"crossref","first-page":"e1003917","DOI":"10.1371\/journal.ppat.1003917","article-title":"Gem-induced cytoskeleton remodeling increases cellular migration of HTLV-1-infected cells, formation of infected-to-target T-cell conjugates and viral transmission","volume":"10","author":"Chevalier","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2015.09.004_bib0660","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/onc.2010.537","article-title":"Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ, and therapy","volume":"30","author":"Matsuoka","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.coviro.2015.09.004_bib0665","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1073\/pnas.92.4.1057","article-title":"Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type I","volume":"92","author":"Grossman","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2015.09.004_bib0670","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nm1389","article-title":"Thymus-derived leukemia\u2013lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I","volume":"12","author":"Hasegawa","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.coviro.2015.09.004_bib0675","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2013.00049","article-title":"A transgenic mouse model of human T cell leukemia virus type 1-associated diseases","volume":"4","author":"Ohsugi","year":"2013","journal-title":"Front Microbiol"},{"key":"10.1016\/j.coviro.2015.09.004_bib0680","doi-asserted-by":"crossref","first-page":"e1004458","DOI":"10.1371\/journal.ppat.1004458","article-title":"HTLV-1 Tax stabilizes MCL-1 via TRAF6-dependent K63-linked polyubiquitination to promote cell survival and transformation","volume":"10","author":"Choi","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2015.09.004_bib0685","doi-asserted-by":"crossref","first-page":"e1004418","DOI":"10.1371\/journal.ppat.1004418","article-title":"A critical role for IL-17RB signaling in HTLV-1 Tax-induced NFkB activation and T cell transformation","volume":"10","author":"Lavorgna","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2015.09.004_bib0690","doi-asserted-by":"crossref","first-page":"e42226","DOI":"10.1371\/journal.pone.0042226","article-title":"HTLV-1 tax increases genetic instability by inducing DNA double strand breaks during DNA replication and switching repair to NHEJ","volume":"7","author":"Baydoun","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.coviro.2015.09.004_bib0695","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0092-8674(00)81148-4","article-title":"Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1","volume":"93","author":"Jin","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2015.09.004_bib0700","doi-asserted-by":"crossref","first-page":"36311","DOI":"10.1074\/jbc.M804931200","article-title":"HTLV-1 Tax oncoprotein subverts the cellular DNA damage response via binding to DNA-dependent protein kinase","volume":"283","author":"Durkin","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coviro.2015.09.004_bib0705","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M004397200","article-title":"Suppression of DNA repair by HTLV-I Tax is rescued by a functional p53 signaling pathway","author":"Kao","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coviro.2015.09.004_bib0710","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1182\/blood-2011-05-356790","article-title":"Interaction of HTLV-1 Tax with minichromosome maintenance proteins accelerates the replication timing program","volume":"119","author":"Boxus","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.coviro.2015.09.004_bib0715","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/1742-4690-9-114","article-title":"Wip1 and p53 contribute to HTLV-1 Tax-induced tumorigenesis","volume":"9","author":"Zane","year":"2012","journal-title":"Retrovirology"},{"key":"10.1016\/j.coviro.2015.09.004_bib0720","doi-asserted-by":"crossref","first-page":"5620","DOI":"10.1073\/pnas.86.14.5620","article-title":"Detection of mRNA for the tax1\/rex1 gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by using the polymerase chain reaction","volume":"86","author":"Kinoshita","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2015.09.004_bib0725","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1742-4690-6-71","article-title":"The HBZ gene, a key player in HTLV-1 pathogenesis","volume":"6","author":"Matsuoka","year":"2009","journal-title":"Retrovirology"},{"key":"10.1016\/j.coviro.2015.09.004_bib0730","doi-asserted-by":"crossref","first-page":"e1001117","DOI":"10.1371\/journal.ppat.1001274","article-title":"HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo","volume":"7","author":"Satou","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2015.09.004_bib0735","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1073\/pnas.0507631103","article-title":"HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells","volume":"103","author":"Satou","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2015.09.004_bib0740","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1182\/blood-2008-04-154286","article-title":"Human T-cell leukemia virus type-1 antisense-encoded gene Hbz, promotes T-lymphocyte proliferation","volume":"112","author":"Arnold","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.coviro.2015.09.004_bib0745","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1742-4690-4-92","article-title":"HTLV-1 HBZ cooperates with JunD to enhance transcription of the human telomerase reverse transcriptase gene (hTERT)","volume":"4","author":"Kuhlmann","year":"2007","journal-title":"Retrovirology"},{"key":"10.1016\/j.coviro.2015.09.004_bib0750","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1182\/blood-2006-03-007732","article-title":"HBZ, a new important player in the mystery of adult T-cell leukemia","volume":"108","author":"Mesnard","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.coviro.2015.09.004_bib0755","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1182\/blood-2008-06-161729","article-title":"Human T-cell leukemia virus type 1 bZIP factor selectively suppresses the classical pathway of NF-kappaB","volume":"113","author":"Zhao","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.coviro.2015.09.004_bib0760","doi-asserted-by":"crossref","first-page":"e1002480","DOI":"10.1371\/journal.ppat.1002025","article-title":"NF-kB hyperactivation by HTLV-1 tax induces cellular senescence, but can be alleviated by the viral anti-sense protein HBZ","volume":"7","author":"Zhi","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2015.09.004_bib0765","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1038\/onc.2012.450","article-title":"HTLV-1 bZIP factor dysregulates the Wnt pathways to support proliferation and migration of adult T-cell leukemia cells","volume":"32","author":"Ma","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.coviro.2015.09.004_bib0770","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1128\/JVI.69.5.2863-2868.1995","article-title":"Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy","volume":"69","author":"Wattel","year":"1995","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2015.09.004_bib0775","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1182\/blood-2012-07-445593","article-title":"HTLV-1-infected T cells contain a single integrated provirus in natural infection","volume":"120","author":"Cook","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.coviro.2015.09.004_sbref0780","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1182\/blood-2014-02-553602","article-title":"The role of HTLV-1 clonality, proviral structure, and genomic integration site in adult T-cell leukemia\/lymphoma","volume":"123","author":"Cook","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.coviro.2015.09.004_bib0785","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1182\/blood-2010-10-312926","article-title":"The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones","volume":"117","author":"Gillet","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.coviro.2015.09.004_bib0790","doi-asserted-by":"crossref","first-page":"e1003271","DOI":"10.1371\/journal.ppat.1003271","article-title":"Genome-wide determinants of proviral targeting clonal abundance and expression in natural HTLV-1 infection","volume":"9","author":"Melamed","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2015.09.004_sbref0795","doi-asserted-by":"crossref","first-page":"e1003646","DOI":"10.1371\/journal.pcbi.1003646","article-title":"Quantification of HTLV-1 clonality and TCR diversity","volume":"10","author":"Laydon","year":"2014","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.coviro.2015.09.004_bib0800","doi-asserted-by":"crossref","first-page":"8035","DOI":"10.1073\/pnas.0608832104","article-title":"In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infection","volume":"104","author":"Asquith","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2015.09.004_sbref0805","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1126\/science.1260825","article-title":"Cancer etiology Variation in cancer risk among tissues can be explained by the number of stem cell divisions","volume":"347","author":"Tomasetti","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.coviro.2015.09.004_bib0810","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.semcancer.2013.11.003","article-title":"HTLV-1 clonality in adult T-cell leukaemia and non-malignant HTLV-1 infection","volume":"26C","author":"Bangham","year":"2014","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.coviro.2015.09.004_bib0815","doi-asserted-by":"crossref","first-page":"e1004006","DOI":"10.1371\/journal.ppat.1004006","article-title":"Clonality of HTLV-2 in natural infection","volume":"10","author":"Melamed","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2015.09.004_bib0820","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood.V89.3.948","article-title":"Integration patterns of HTLV-I provirus in relation to the clinical course of ATL: frequent clonal change at crisis from indolent disease","volume":"89","author":"Tsukasaki","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.coviro.2015.09.004_bib0825","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1182\/blood-2013-06-508861","article-title":"An animal model of adult T-cell leukemia humanized mice with HTLV-1 specific immunity","volume":"123","author":"Tezuka","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.coviro.2015.09.004_bib0830","doi-asserted-by":"crossref","first-page":"e1002231","DOI":"10.1371\/journal.ppat.1002231","article-title":"HTLV-1 propels thymic human T cell development in \u2018human immune system\u2019 Rag2\u2212\/\u2212IL-2Rgammac\u2212\/\u2212 mice","volume":"7","author":"Villaudy","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2015.09.004_bib0835","first-page":"74","article-title":"The neutralizing function of the anti-HTLV-1 antibody is essential in preventing in vivo transmission of HTLV-1 to human T cells in NOD-SCID\/inverted question markcnull (NOG) mice","volume":"11","author":"Saito","year":"2014","journal-title":"Retrovirology"},{"key":"10.1016\/j.coviro.2015.09.004_bib0840","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1182\/asheducation-2014.1.559","article-title":"Chimeric antigen receptor T-cell therapy for ALL","author":"Maude","year":"2014","journal-title":"Hematology"},{"key":"10.1016\/j.coviro.2015.09.004_bib0845","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1200\/JCO.2014.59.4358","article-title":"Immune checkpoint blockade in cancer therapy","volume":"33","author":"Postow","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.coviro.2015.09.004_bib0850","doi-asserted-by":"crossref","first-page":"e1003263","DOI":"10.1371\/journal.ppat.1003263","article-title":"Strongyloidiasis and infective dermatitis alter human T lymphotropic virus-1 clonality in vivo","volume":"9","author":"Gillet","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2015.09.004_bib0855","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1126\/science.1235122","article-title":"Cancer genome landscapes","volume":"339","author":"Vogelstein","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.coviro.2015.09.004_sbref0860","series-title":"Landscape of Genetic Alterations in Adult T-cell Leukemia\/Lymphoma","author":"Kataoka","year":"2014"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187962571500139X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187962571500139X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T21:35:26Z","timestamp":1599600926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187962571500139X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":86,"alternative-id":["S187962571500139X"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2015.09.004","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How does HTLV-1 cause adult T-cell leukaemia\/lymphoma (ATL)?","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2015.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}